IMAX: ``not aware of any corporate developments to account for this activity''
IMAX Corp. released a statement a few minutes ago saying that it is not aware of any corporate developments to account for the unusual activity in its stock price.
Imaxio, a biotech company based in Lyon, specializing in protein engineering for immunotherapy, has just signed a worldwide licensing agreement with the American company Wyeth and the Massachusetts General Hospital in Boston.